The New England Journal of Medicine

Pulmonary Dysfunction in Systemic Lupus Erythematosus

ABNORMALITIES of respiratory function have been observed in scleroderma. 1–5 However, little attention has been paid to the study of the pulmonary function of patients with systemic lupus ...
Medscape

Does Immunosuppression Prevent Pulmonary Arterial Hypertension in Systemic Sclerosis?

MANCHESTER, England — Use of immunosuppressive drugs within 5 years of the onset of systemic sclerosis (SSc) did not lower patients’ risk for developing pulmonary arterial hypertension (PAH) but was ...
Business Insider

Phase III study showed Ofev® slows the loss of pulmonary function in people living with systemic sclerosis associated ILD

RIDGEFIELD, Conn., May 20, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity ...
JSTOR Daily

The Role of Cardiac Shunts in the Regulation of Arterial Blood Gases

This is a preview. Log in through your library . Abstract The pulmonary and systemic circulations are not completely separated in reptiles and amphibians, so oxygen-rich blood returning from the lungs ...
Nature

Elevated arterial blood pressure after superior cavo-pulmonary anastomosis is associated with elevated pulmonary artery pressure and cerebrovascular dysautoregulation

Elevated arterial blood pressure (ABP) is common after superior bidirectional cavopulmonary anastomosis (BCPA). The effects of elevated ABP after BCPA on cerebrovascular hemodynamics are unknown. We ...
Business Wire

Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD

INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced that the SENSCIS ® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVC a) in ...